181 related articles for article (PubMed ID: 9434579)
21. Advanced glycation end products, their receptors and diabetic angiopathy.
Wautier JL; Guillausseau PJ
Diabetes Metab; 2001 Nov; 27(5 Pt 1):535-42. PubMed ID: 11694852
[TBL] [Abstract][Full Text] [Related]
22. The Maillard or browning reaction in diabetes.
John WG; Lamb EJ
Eye (Lond); 1993; 7 ( Pt 2)():230-7. PubMed ID: 7607341
[No Abstract] [Full Text] [Related]
23. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth.
Wang R; Kudo M; Yokoyama M; Asano G
J Nippon Med Sch; 2001 Dec; 68(6):472-81. PubMed ID: 11744927
[TBL] [Abstract][Full Text] [Related]
24. [Advanced glycation end products and hyperglycaemia].
Omsland TK; Bangstad HJ; Berg TJ; Kolset SO
Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936
[TBL] [Abstract][Full Text] [Related]
25. Hyperglycemia and cardiovascular disease.
Duckworth WC
Curr Atheroscler Rep; 2001 Sep; 3(5):383-91. PubMed ID: 11487449
[TBL] [Abstract][Full Text] [Related]
26. [Possible participation of advanced glycation endproducts and their receptor system in the development of diabetic vascular complications].
Yamamoto Y; Sakurai S; Watanabe T; Yonekura H; Yamamoto H
Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):49-55. PubMed ID: 12617038
[TBL] [Abstract][Full Text] [Related]
27. Diabetic macrovascular disease: the glucose paradox?
Libby P; Plutzky J
Circulation; 2002 Nov; 106(22):2760-3. PubMed ID: 12450998
[No Abstract] [Full Text] [Related]
28. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
[No Abstract] [Full Text] [Related]
29. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs.
Xue J; Ray R; Singer D; Böhme D; Burz DS; Rai V; Hoffmann R; Shekhtman A
Biochemistry; 2014 May; 53(20):3327-35. PubMed ID: 24824951
[TBL] [Abstract][Full Text] [Related]
30. Increased adhesion of lymphoid cells to glycated proteins.
Ivanov GI; Chaushev TA; Dakovska LN; Kyurkchiev SD
Int J Biochem Cell Biol; 1999 Jul; 31(7):797-804. PubMed ID: 10467736
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.
Pinto RS; Machado UF; Passarelli M
Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293
[No Abstract] [Full Text] [Related]
32. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
Chiarelli F; Mansour M; Verrotti A
Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
[No Abstract] [Full Text] [Related]
33. Evolution and diabetic vasculopathy.
Yamamoto H; Yamamoto Y
J Diabetes Investig; 2022 Jul; 13(7):1111-1113. PubMed ID: 35598317
[TBL] [Abstract][Full Text] [Related]
34. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
[TBL] [Abstract][Full Text] [Related]
35. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
Xu Y; He Z; King GL
Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
[TBL] [Abstract][Full Text] [Related]
36. RAGE: a novel target for drug intervention in diabetic vascular disease.
Hudson BI; Schmidt AM
Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
[TBL] [Abstract][Full Text] [Related]
37. Hyperglycemia and the pathobiology of diabetic complications.
Aronson D
Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
[TBL] [Abstract][Full Text] [Related]
38. Association between acute respiratory failure requiring mechanical ventilation and the production of advanced glycation end products.
Edriss H; Molehin AJ; Gavidia R; Selvan K; Nugent K
J Investig Med; 2020 Oct; 68(7):1235-1240. PubMed ID: 32859644
[TBL] [Abstract][Full Text] [Related]
39. RAGE in diabetic nephropathy.
Yamamoto H; Watanabe T; Yamamoto Y; Yonekura H; Munesue S; Harashima A; Ooe K; Hossain S; Saito H; Murakami N
Curr Mol Med; 2007 Dec; 7(8):752-7. PubMed ID: 18331233
[TBL] [Abstract][Full Text] [Related]
40. [AGE and AGE-receptors].
Ohgami N; Nagai R; Nakayama H; Horiuchi S
Seikagaku; 2001 Mar; 73(3):200-4. PubMed ID: 11321842
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
